HTERT promotes the invasion of gastric cancer cells by enhancing FOXO3a ubiquitination and subsequent ITGB1 upregulation

Gut

Volumn 66, Issue 1, 2017, Pages 31-42

  Hu, Changjiang ^a   Ni, Zhenghong ^a   Li, Bo Sheng ^a   Yong, Xin ^a   Yang, Xin ^a   Zhang, Jian Wei ^a   Zhang, Dan ^a   Qin, Yong ^a   Jie, Meng Meng ^a   Dong, Hui ^a,b   Li, Song ^c   He, Fengtian ^a   Yang, Shi Ming ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; FORKHEAD BOX PROTEIN M1; GLUTATHIONE TRANSFERASE; PROTEIN MDM2; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHRL1; UBIQUITIN; FOXM1 PROTEIN, HUMAN; FOXO3 PROTEIN, HUMAN; FOXO3 PROTEIN, MOUSE; MDM2 PROTEIN, HUMAN; TELOMERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CANCER CELL LINE; CANCER TISSUE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUDE MOUSE; POLYMERASE CHAIN REACTION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEOMICS; QUANTITATIVE ANALYSIS; STOMACH CANCER; TUMOR INVASION; TUMOR XENOGRAFT; UBIQUITINATION; UPREGULATION; WESTERN BLOTTING; ANIMAL; CELL MOTION; GENETICS; LUNG TUMOR; LYMPH NODE METASTASIS; METABOLISM; PATHOLOGY; SECONDARY; SIGNAL TRANSDUCTION; STOMACH TUMOR; SURVIVAL RATE; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD29; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; FORKHEAD BOX PROTEIN M1; FORKHEAD BOX PROTEIN O3; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS C-MDM2; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; SURVIVAL RATE; TELOMERASE; UBIQUITINATION; UP-REGULATION;

EID: 84941670635     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2015-309322     Document Type: Article

References (39)

1. Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 2009;9:274-84.
2. Hahn WC, Stewart SA, Brooks MW, et al. Inhibition of telomerase limits the growth of human cancer cells. Nat Med 1999;5:1164-70.
3. Qian Y, Yang L, Cao S. Telomeres and telomerase in T cells of tumor immunity. Cell Immunol 2014;289:63-9.
4. Tabori U, Ma J, Carter M, et al. Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma. J Clin Oncol 2006;24:1522-8.
5. Wang L, Li PF, Geng M, et al. Correlation between chemosensitivity to anticancer drugs and telomerase reverse transcriptase mRNA expression in gastric cancer. Diagn Pathol 2013;8:33.
6. Elias BC, Mathew S, Srichai MB, et al. The integrin beta1 subunit regulates paracellular permeability of kidney proximal tubule cells. J Biol Chem 2014;289:8532-44.
7. Barkan D, Chambers AF. Beta 1-integrin: a potential therapeutic target in the battle against cancer recurrence. Clin Cancer Res 2011;17:7219-23.
8. Miranti CK, Brugge JS. Sensing the environment: a historical perspective on integrin signal transduction. Nat Cell Biol 2002;4:E83-90.
9. White DE, Kurpios NA, Zuo D, et al. Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell 2004;6:159-70.
10. Kaplan-Turkoz B, Jimenez-Soto LF, Dian C, et al. Structural insights into Helicobacter pylori oncoprotein CagA interaction with beta 1 integrin. Proc Natl Acad Sci USA 2012;109:14640-5.
11. Chen L, Lu MH, Zhang D, et al. miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase. Cell Death Dis 2014;5:e1034.
12. Hu C, Liu D, Zhang Y, et al. LXRalpha-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells. Oncogene 2014;33:2888-97.
13. Xiong Z, Lu MH, Fan YH, et al. Downregulation of heparanase by RNA interference inhibits invasion and tumorigenesis of hepatocellular cancer cells in vitro and in vivo. Int J Oncol 2012;40:1601-9.
14. He W, Huang C, Luo G, Dal Pra et al. A stable panel comprising 18 urinary proteins in the human healthy population. Proteomics 2012;12:1059-72.
15. Desiderio UV, Zhu X, Evans JP. ADAM2 interactions with mouse eggs and cell lines expressing alpha4/alpha9 (ITGA4/ITGA9) integrins: implications for integrin-based adhesion and fertilization. PLoS One 2010;5:e13744.
16. Hu CJ, Wang B, Tang B, et al. The FOXM1-induced resistance to oxaliplatin is partially mediated by its novel target gene Mcl-1 in gastric cancer cells. BBA-Gene Regul Mech 2015;1849:290-9.
17. Massa TM, Yang ML, Ho JY, et al. Fibrinogen surface distribution correlates to platelet adhesion pattern on fluorinated surface-modified polyetherurethane. Biomaterials 2005;26:7367-76.
18. Peters K, Schmidt H, Unger RE, et al. Software-supported image quantification of angiogenesis in an in vitro culture system: application to studies of biocompatibility. Biomaterials 2002;23:3413-19.
19. McDonald GB, Tabellini L, Storer BE, et al. Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment. Blood 2015;126:113-20.
20. Xu X, Lu D, Ling Q, et al. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria. Gut 2016;65:1035-41.
21. Cucchetti A, Vivarelli M, Heaton ND, et al. Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease. Gut 2007;56:253-8.
22. Chou CC, Lee KH, Lai IL, et al. AMPK reverses the mesenchymal phenotype of cancer cells by targeting the Akt-MDM2-FOXO3a signaling axis. Cancer Res 2014;74:4783-95.
23. Ghosh A, Saginc G, Leow SC, et al. Telomerase directly regulates NF-kappaB-dependent transcription. Nat Cell Biol 2012;14:1270-81.
24. Park JI, Venteicher AS, Hong JY, et al. Telomerase modulates Wnt signalling by association with target gene chromatin. Nature 2009;460:66-72.
25. Su JL, Cheng X, Yamaguchi H, et al. FOXO3a-dependent mechanism of E1A-induced chemosensitization. Cancer Res 2011;71:6878-87.
26. Yang JY, Zong CS, Xia W, et al. ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat Cell Biol 2008;10:138-48.
27. Storz P, Doppler H, Copland JA, et al. FOXO3a promotes tumor cell invasion through the induction of matrix metalloproteinases. Mol Cell Biol 2009;29:4906-17.
28. Sisci D, Maris P, Cesario MG, et al. The estrogen receptor alpha is the key regulator of the bifunctional role of FOXO3a transcription factor in breast cancer motility and invasiveness. Cell Cycle 2013;12:3405-20.
29. Shiota M, Song Y, Yokomizo A, et al. Foxo3a suppression of urothelial cancer invasiveness through Twist1, Y-box-binding protein 1, and E-cadherin regulation. Clin Cancer Res 2010;16:5654-63.
30. Ni D, Ma X, Li HZ, et al. Downregulation of FOXO3a promotes tumor metastasis and is associated with metastasis-free survival of patients with clear cell renal cell carcinoma. Clin Cancer Res 2014;20:1779-90.
31. Zhao Y, Yu H, Hu W. The regulation of MDM2 oncogene and its impact on human cancers. Acta Biochim Biophys Sin (Shanghai) 2014;46:180-9.
32. Li M, Brooks CL, Wu-Baer F, et al. Mono-versus polyubiquitination: differential control of p53 fate by Mdm2. Science 2003;302:1972-5.
33. Xiao ZX, Chen J, Levine AJ, et al. Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 1995;375:694-8.
34. Fu W, Ma Q, Chen L, et al. MDM2 acts downstream of p53 as an E3 ligase to promote FOXO ubiquitination and degradation. J Biol Chem 2009;284:13987-4000.
35. Yang JY, Zong CS, Xia W, et al. MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation. Mol Cell Biol 2006;26:7269-82.
36. Oh W, Lee EW, Lee D, et al. Hdm2 negatively regulates telomerase activity by functioning as an E3 ligase of hTERT. Oncogene 2010;29:4101-12.
37. Zhang X, Cheng L, Minn K, et al. Targeting of mutant p53-induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cells. Oncotarget 2014;5:11365-80.
38. Ding D, Xi P, Zhou J, et al. Human telomerase reverse transcriptase regulates MMP expression independently of telomerase activity via NF-kappaB-dependent transcription. FASEB J 2013;27:4375-83.
39. Liu Z, Li Q, Li K, et al. Telomerase reverse transcriptase promotes epithelialmesenchymal transition and stem cell-like traits in cancer cells. Oncogene 2013;32:4203-13.